To assess whether the observed increase in OXPHOS was sufficient to compensate for reduced glycolytic activity upon LDHA inhibition in AML cells, we measured phosphorylation of 5’ AMP-activated protein kinase (AMPK), which acts as a key cellular energy sensor. This evidence concerns the gene LDHA and acute myeloid leukemia.